Related Experiment Video

Updated: Mar 19, 2026

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
08:40

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline

Published on: November 29, 2016

10.9K

Tumors topple when ERKs uncouple

Ana Herrero1, Piero Crespo2

  • 1Systems Biology Ireland, Conway Institute, University College Dublin , Belfield, Dublin, Ireland.

Molecular & Cellular Oncology
|June 17, 2016
PubMed

Insights

Targeting the RAS-ERK pathway with a new inhibitor that blocks ERK dimerization shows promise in preventing tumor progression. This approach highlights the potential of targeting protein interactions for cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The RAS-ERK pathway is frequently dysregulated in various cancers.
  • Current therapies often target kinase activity within this pathway.
  • Inhibiting protein-protein interactions presents an alternative therapeutic strategy.

Purpose of the Study:

  • To investigate the efficacy of targeting ERK dimerization in tumors with oncogenic RAS and BRAF mutations.
  • To demonstrate the potential of targeting regulatory protein-protein interactions in cancer treatment.

Main Methods:

  • Utilized a small-molecule inhibitor designed to block ERK dimerization.
  • Assessed the inhibitor's effect on tumor progression in preclinical models harboring RAS-ERK pathway alterations.

Main Results:

  • The small-molecule inhibitor of ERK dimerization effectively halted tumor progression.
  • This demonstrates the therapeutic potential of targeting protein-protein interactions in the RAS-ERK pathway.

Conclusions:

  • Targeting ERK dimerization is a viable strategy for treating RAS-ERK pathway-driven cancers.
  • Disrupting regulatory protein-protein interactions offers a novel therapeutic avenue in oncology.
Keywords:
Antitumor therapy; dimerization inhibitor; ERK

More Related Videos

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

9.4K
Induction and Analysis of Epithelial to Mesenchymal Transition10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

36.7K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Abnormal Proliferation02:23

Abnormal Proliferation

3.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K